The Present and Future Global Burden of the Inherited Disorders of Hemoglobin

Hematology/Oncology Clinics of North America

Volumn 30, Issue 2, 2016, Pages 327-341

  Piel, Frédéric B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Consanguinity; Genetic disease; Human migrations; Malaria selection; Newborn screening; Public health; Sickle cell disease; Thalassemias

Indexed keywords

HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN S;

ALPHA THALASSEMIA; BETA THALASSEMIA; CONSANGUINITY; ECONOMIC DEVELOPMENT; HEMOGLOBIN D DISEASE; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; MIGRATION; PATIENT ASSESSMENT; POPULATION GROWTH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STRATIFIED SAMPLE; THALASSEMIA; COST OF ILLNESS; DEVELOPING COUNTRY; GLOBAL HEALTH; HEMOGLOBINOPATHIES; RISK FACTOR;

COST OF ILLNESS; DEVELOPING COUNTRIES; GLOBAL HEALTH; HEMOGLOBINOPATHIES; HUMANS; RISK FACTORS;

EID: 84956626169     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2015.11.004     Document Type: Review

References (61)

1. Weatherall D., Akinyanju O., Fucharoen S., et al. Inherited disorders of hemoglobin. Disease control priorities in developing countries 2006, 663-680. World Bank, Washington, DC. 2nd edition. D.T. Jamison, J.G. Breman, A.R. Measham (Eds.).
2. Weatherall D.J. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol 2011, 154(6):736-744.
3. Weatherall D.J. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010, 115(22):4331-4336.
4. Giardine B., Borg J., Viennas E., et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res 2014, 42(Database issue):D1063-D1069.
5. Rees D.C., Williams T.N., Gladwin M.T. Sickle-cell disease. Lancet 2010, 376(9757):2018-2031.
6. Piel F.B., Patil A.P., Howes R.E., et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010, 1:104.
7. Piel F.B., Patil A.P., Howes R.E., et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013, 381(9861):142-151.
8. Piel F.B., Howes R.E., Patil A.P., et al. The distribution of haemoglobin C and its prevalence in newborns in Africa. Sci Rep 2013, 3:1671.
9. Weatherall D.J., Clegg J.B. The thalassaemia syndromes 2001, Blackwell Science, Oxford (United Kingdom); Malden (MA). 4th edition.
10. Piel F.B., Weatherall D.J. The α-thalassemias. N Engl J Med 2014, 371(20):1908-1916.
11. Weatherall D.J. The importance of micromapping the gene frequencies for the common inherited disorders of haemoglobin. Br J Haematol 2010, 149(5):635-637.
12. Suresh S., Fisher C., Ayyub H., et al. Alpha thalassaemia and extended alpha globin genes in Sri Lanka. Blood Cells Mol Dis 2013, 50(2):93-98.
13. Weatherall D. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res 2011, 134:493-497.
14. Streetly A., Latinovic R., Hall K., et al. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol 2009, 62(1):26-30.
15. World Health Organization Sickle-cell anaemia (WHA59.20). Fifty-ninth world health assembly resolutions and decisions 2006, WHO, Geneva (Switzerland).
16. WHO Executive Board Resolution on thalassaemia and other haemoglobinopathies (EB118.R1), 118th session 2008, WHO, Geneva (Switzerland).
17. Global Burden of Diseases IaRF. Available at: . Accessed June 30, 2015. http://www.healthdata.org/gbd.
18. Thalassemia International Federation. Available at: . Accessed June 30, 2015. http://www.thalassaemia.org.cy/.
19. Global Sickle Cell Disease Network. Available at: . Accessed June 30, 2015. http://globalsicklecelldisease.org/.
20. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005, 77(2):171-192.
21. Hedrick P.W. Population genetics of malaria resistance in humans. Heredity (Edinb) 2011, 107(4):283-304.
22. Haldane J.B.S. The rate of mutation of human genes. Hereditas 1949, 35(S1):267-273.
23. Allison A.C. Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 1954, 1(4857):290-294.
24. Williams T.N., Weatherall D.J. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2012, 2(9):a011692.
25. Williams T.N., Mwangi T.W., Wambua S., et al. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet 2005, 37(11):1253-1257.
26. Penman B.S., Pybus O.G., Weatherall D.J., et al. Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean. Proc Natl Acad Sci U S A 2009, 106(50):21242-21246.
27. Elguero E., Delicat-Loembet L.M., Rougeron V., et al. Malaria continues to select for sickle cell trait in central Africa. Proc Natl Acad Sci U S A 2015, 112(22):7051-7054.
28. Veytsman B. Environment change, geographic migration and sickle cell anaemia. Evol Ecol 1997, 11(5):519-529.
29. Hanchard N.A., Hambleton I., Harding R.M., et al. The frequency of the sickle allele in Jamaica has not declined over the last 22 years. Br J Haematol 2005, 130(6):939-942.
30. Hanchard N.A., Hambleton I., Harding R.M., et al. Predicted declines in sickle allele frequency in Jamaica using empirical data. Am J Hematol 2006, 81(11):817-823.
31. Hamamy H. Consanguineous marriages: preconception consultation in primary health care settings. J Community Genet 2012, 3(3):185-192.
32. Bittles A.H., Black M.L. Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A 2010, 107(Suppl 1):1779-1786.
33. Modell B., Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008, 86:480-487.
34. Piel F.B., Hay S.I., Gupta S., et al. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med 2013, 10(7):e1001484.
35. Omran A.R. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005, 83(4):731-757.
36. Rajaratnam J.K., Marcus J.R., Flaxman A.D., et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards millennium development goal 4. Lancet 2010, 375(9730):1988-2008.
37. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385(9963):117-171. GBD 2013 Mortality and Causes of Death Collaborators.
38. Gaston M.H., Verter J.I., Woods G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med 1986, 314(25):1593-1599.
39. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339(1):5-11.
40. Piel F.B., Tatem A.J., Huang Z., et al. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. Lancet Glob Health 2014, 2(2):e80-e89.
41. Schroeder W.A., Munger E.S., Powars D.R. Sickle cell anaemia, genetic variations, and the slave trade to the United States. J Afr Hist 1990, 31(2):163-180.
42. Pante-de-Sousa G., Mousinho-Ribeiro R.D.C., Santos E.J.M.D., et al. Origin of the hemoglobin S gene in a Northern Brazilian population: the combined effects of slave trade and internal migrations. Genet Mol Biol 1998, 21:427-430.
43. Vichinsky E.P., MacKlin E.A., Waye J.S., et al. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics 2005, 116(6):e818-e825.
44. Aguilar Martinez P., Angastiniotis M., Eleftheriou A., et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis 2014, 9:97.
45. Mohammed A.O., Attalla B., Bashir F.M.K., et al. Relationship of the sickle cell gene to the ethnic and geographic groups populating the Sudan. Community Genet 2006, 9(2):113-120.
46. McBride K.L., Snow K., Kubik K.S., et al. Hb Dartmouth [α66(E15)Leu → Pro (α2) (CTG → CCG)]: a novel α2-globin gene mutation associated with severe neonatal anemia when inherited in trans with Southeast Asian α-thalassemia-1. Hemoglobin 2001, 25(4):375-382.
47. Garnier-Géré P., Chikhi L. Population subdivision, Hardy-Weinberg equilibrium and the Wahlund effect 2001, Chichester: John Wiley & Sons, Ltd.
48. Overall A.D., Ahmad M., Thomas M.G., et al. An analysis of consanguinity and social structure within the UK Asian population using microsatellite data. Ann Hum Genet 2003, 67(Pt 6):525-537.
49. Livingstone F.B. Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations 1985, Oxford University Press, New York.
50. Piel F.B., Adamkiewitzc T.V., Amendah D.D., et al. Observed and expected frequencies of structural haemoglobin variants in newborn screening programmes in Africa and the Middle East. Genetics in Medicine 2015, [Epub ahead of print].
51. Howes R.E., Patil A.P., Piel F.B., et al. The global distribution of the Duffy blood group. Nat Commun 2011, 2:266.
52. Howes R.E., Piel F.B., Patil A.P., et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 2012, 9(11):e1001339.
53. Grosse S.D., Odame I., Atrash H.K., et al. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 2011, 41(6 Suppl 4):S398-S405.
54. Hassell K.L. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010, 38(4 Suppl):S512-S521.
55. Angastiniotis M.A., Hadjiminas M.G. Prevention of thalassaemia in Cyprus. Lancet 1981, 1(8216):369-371.
56. Cao A., Kan Y.W. The prevention of thalassemia. Cold Spring Harb Perspect Med 2013, 3(2):a011775.
57. Al Arrayed S., Al Hajeri A. Newborn screening services in Bahrain between 1985 and 2010. Adv Hematol 2012, 2012:4.
58. Steinberg M.H. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005, 129(4):465-481.
59. Kauf T.L., Coates T.D., Huazhi L., et al. The cost of health care for children and adults with sickle cell disease. Am J Hematol 2009, 84(6):323-327.
60. Colah R., Gorakshakar A., Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol 2010, 3(1):103-117.
61. Weatherall D.J. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001, 2(4):245-255.